Skip to main content

ADVERTISEMENT

mixed aortic valve disease

Original Contribution
05/06/2022

Martino Pepe, MD, PhD1;  Nicola Corcione, MD2;  Palma Luisa Nestola, MD1; Francesco Bedogni, MD3;  Sergio Berti, MD4;  Alberto Morello, MD2; Alessandro Iadanza, MD5;  Antonio L. Bartorelli, MD6,7;  Paolo Ferraro, MD8; Carmen Spaccarotella, MD9,10;  Gennaro Sardella, MD11;  Michele Cimmino, MD8-; Michele Albanese, MD8;  Marcello De Giosa, MMaths12;  Giuseppe Biondi-Zoccai, MD, MStat13,14;  Arturo Giordano, MD, PhD2

Martino Pepe, MD, PhD1;  Nicola Corci...
The differential outcomes between pure/predominant aortic stenosis (AS) and mixed aortic valve disease (MAVD) in patients undergoing transcatheter aortic valve implantation (TAVI) are still debated. The aim of this analysis was to evaluate...
The differential outcomes between pure/predominant aortic stenosis (AS) and mixed aortic valve disease (MAVD) in patients undergoing transcatheter aortic valve implantation (TAVI) are still debated. The aim of this analysis was to evaluate...
The differential outcomes...
05/06/2022
Journal of Invasive Cardiology